Related Experiment Video
Updated: Feb 2, 2026

Dynamic Adhesion Assay for the Functional Analysis of Anti-adhesion Therapies in Inflammatory Bowel Disease
Published on: September 20, 2018
Epigenetics, DNA Organization, and Inflammatory Bowel Disease
Greeshma Ray1, Michelle S Longworth1
1Department of Cellular and Molecular Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Epigenetic changes and chromatin organization play a key role in inflammatory bowel diseases (IBD) development. Understanding these epigenetic factors may offer new diagnostic and therapeutic strategies for IBD.
Area of Science:
- Gastroenterology
- Immunology
- Epigenetics
Background:
- Inflammatory bowel diseases (IBD) are chronic gastrointestinal disorders with increasing incidence.
- Genetics, environment, microbiota, and immune factors contribute to IBD pathogenesis.
- Epigenetic modifications and chromatin organization are emerging as crucial factors influencing IBD.
Purpose of the Study:
- To review the role of epigenetic modifications and chromatin organization in IBD.
- To summarize links between epigenetic factors, associated proteins, and IBD development.
- To explore the implications for IBD diagnosis and treatment.
Main Methods:
- Literature review focusing on epigenetic mechanisms in IBD.
- Analysis of studies linking epigenetic marks and chromatin organization to IBD pathogenesis.
- Discussion of proteins involved in epigenetic regulation in the context of IBD.
Main Results:
- Epigenetic changes and altered chromatin organization are associated with differential gene expression in IBD patients.
- These epigenetic factors influence intestinal homeostasis, immune cell development, and immune responses.
- While direct evidence for histone modifications is limited, their role is being investigated.
Conclusions:
- Epigenetics and chromatin organization are significant contributors to IBD onset and progression.
- Understanding these mechanisms can lead to novel diagnostic and therapeutic approaches for IBD.
- Further research into histone modifications and DNA contact organization is warranted for IBD management.
More Related Videos
Related Concept Videos
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Epigenetic Regulation

